Boston Scientific BSX Latin America and Canada — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Boston Scientific's latin america and canada — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Boston Scientific's latin america and canada — net sales?
- Boston Scientific (BSX) reported latin america and canada — net sales of $185M in Q1 2026.
- How has Boston Scientific's latin america and canada — net sales changed year-over-year?
- Boston Scientific's latin america and canada — net sales increased by 19.4% year-over-year, from $155M to $185M.
- What is the long-term trend for Boston Scientific's latin america and canada — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's latin america and canada — net sales has grown at a 15.1% compound annual growth rate (CAGR), from $386M to $678M.
- What does latin america and canada — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and related services within the Latin American and Canadian geographic markets. It reflects the company's ability to capture market share, navigate local regulatory environments, and drive adoption of its interventional medical technologies in these specific regions. Growth in this figure indicates successful commercial execution and increasing demand for the company's product portfolio across these diverse healthcare systems.